{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:30:36Z","timestamp":1785742236309,"version":"3.56.0"},"reference-count":68,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Most bleeding disorders encountered in clinical practice will be diagnosed, at least initially, by phenotypic assays. However, since the characterization of the genes that encode coagulation factors in the 1980s, significant progress has been made in translating this knowledge for diagnostic and therapeutic purposes. For hemophilia A and B, molecular genetic testing to determine carrier status, prenatal diagnosis, and likelihood of inhibitor development or anaphylaxis to infused coagulation factor concentrates is an established component of comprehensive clinical management. In contrast, although significant recent advances in our understanding of the molecular genetic basis of von Willebrand disease (VWD) have allowed for the development of rational approaches to genetic diagnostics, questions remain about this complex genetic disorder and how to incorporate emerging knowledge into diagnostic strategies. This article will review the state-of-the-art for molecular diagnostics for both hemophilia and VWD.<\/jats:p>","DOI":"10.1182\/asheducation-2015.1.152","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T15:23:25Z","timestamp":1473953005000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Using genetic diagnostics in hemophilia and von Willebrand disease"],"prefix":"10.1182","volume":"2015","author":[{"given":"Laura L.","family":"Swystun","sequence":"first","affiliation":[{"name":"Departments of Pathology & Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"James","sequence":"additional","affiliation":[{"name":"Medicine, Queen's University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111703122644300_B1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States: the Hemophilia Surveillance System Project Investigators","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"issue":"3","key":"2019111703122644300_B2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in Hemophilia Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"85","author":"White","year":"2001","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111703122644300_B3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2516.2011.02539.x","article-title":"Clinical severity of haemophilia A: does the classification of the 1950s still stand?","volume":"17","author":"Den Uijl","year":"2011","journal-title":"Haemophilia"},{"key":"2019111703122644300_B4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2516.2004.01005.x","article-title":"Molecular basis of Haemophilia A","volume":"10","author":"Oldenburg","year":"2004","journal-title":"Haemophilia"},{"issue":"6","key":"2019111703122644300_B5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1538-7836.2009.03346.x","article-title":"Molecular mechanisms underlying hemophilia A phenotype in seven females","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2019111703122644300_B6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2006.01361.x","article-title":"Genetic risk factors for inhibitors to factors VIII and IX","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Haemophilia"},{"issue":"11","key":"2019111703122644300_B7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"5992","key":"2019111703122644300_B8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/312326a0","article-title":"Characterization of the human factor VIII gene","volume":"312","author":"Gitschier","year":"1984","journal-title":"Nature"},{"issue":"3","key":"2019111703122644300_B9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"issue":"4","key":"2019111703122644300_B10","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V92.4.1458","article-title":"Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A","volume":"92","author":"Liu","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2019111703122644300_B11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/pd.2393","article-title":"Inverse shifting PCR based prenatal diagnosis of hemophilia-causative inversions involving int22h and int1h hotspots from chorionic villus samples","volume":"29","author":"Radic","year":"2009","journal-title":"Prenat Diagn"},{"key":"2019111703122644300_B12","unstructured":"Rallapalli P Kemball-Cook G Tuddenham E Gomez K Perkins S Factor VIII variant database Accessed April 20, 2015 http:\/\/www.factorviii-db.org\/"},{"issue":"12","key":"2019111703122644300_B13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/ajh.23557","article-title":"The Canadian \u201cNational program for hemophilia mutation testing\u201d database: a ten-year review","volume":"88","author":"Rydz","year":"2013","journal-title":"Am J Hematol"},{"issue":"9","key":"2019111703122644300_B14","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1538-7836.2012.04843.x","article-title":"Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening","volume":"10","author":"Payne","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111703122644300_B15","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1538-7836.2011.04408.x","article-title":"Deep intronic variations may cause mild hemophilia A","volume":"9","author":"Castaman","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"14","key":"2019111703122644300_B16","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/bi00335a049","article-title":"Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)","volume":"24","author":"Yoshitake","year":"1985","journal-title":"Biochemistry"},{"issue":"7","key":"2019111703122644300_B17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111703122644300_B18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia B: Molecular Pathogenesis and Mutation Analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111703122644300_B19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0609.1970.tb01873.x","article-title":"Another genetic variant of haemophilia B: haemophilia B Leyden","volume":"7","author":"Veltkamp","year":"1970","journal-title":"Scand J Haematol"},{"issue":"1","key":"2019111703122644300_B20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tig.2013.09.007","article-title":"Hemophilia B Leyden and once mysterious cis-regulatory mutations","volume":"30","author":"Funnell","year":"2014","journal-title":"Trends Genet"},{"issue":"5","key":"2019111703122644300_B21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1538-7836.2008.02940.x","article-title":"A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter +13 A>G)","volume":"6","author":"James","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2019111703122644300_B22","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2013-02-483263","article-title":"Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A","volume":"122","author":"Eckhardt","year":"2013","journal-title":"Blood"},{"issue":"12","key":"2019111703122644300_B23","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111703122644300_B24","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3270","article-title":"Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A","volume":"19","author":"Pandey","year":"2013","journal-title":"Nat Med"},{"issue":"5","key":"2019111703122644300_B25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2516.2009.02039.x","article-title":"Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)","volume":"15","author":"Chitlur","year":"2009","journal-title":"Haemophilia"},{"issue":"2","key":"2019111703122644300_B26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"6","key":"2019111703122644300_B27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"issue":"1","key":"2019111703122644300_B28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4706","key":"2019111703122644300_B29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand Factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"issue":"1","key":"2019111703122644300_B30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"issue":"19","key":"2019111703122644300_B31","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111703122644300_B32","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/j.1460-2075.1986.tb04435.x","article-title":"Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit","volume":"5","author":"Verweij","year":"1986","journal-title":"EMBO J"},{"issue":"33","key":"2019111703122644300_B33","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111703122644300_B34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"issue":"2","key":"2019111703122644300_B35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2010.08400.x","article-title":"First application of MLPA method in severe von Willebrand disease: confirmation of a new large VWF gene deletion and identification of heterozygous carriers","volume":"152","author":"Cabrera","year":"2011","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111703122644300_B36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH12-02-0089","article-title":"Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients","volume":"108","author":"Yadegari","year":"2012","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111703122644300_B37","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111703122644300_B38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111703122644300_B39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111703122644300_B40","first-page":"630","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019111703122644300_B41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease","volume":"102","author":"O'Brien","year":"2003","journal-title":"Blood"},{"issue":"18","key":"2019111703122644300_B42","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2012-12-471672","article-title":"No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation","volume":"121","author":"Flood","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111703122644300_B43","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2019111703122644300_B44","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood-2013-02-485094","article-title":"Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project","volume":"122","author":"Johnsen","year":"2013","journal-title":"Blood"},{"issue":"26","key":"2019111703122644300_B45","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"issue":"19","key":"2019111703122644300_B46","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"issue":"23","key":"2019111703122644300_B47","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111703122644300_B48","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis","volume":"107","author":"Hassenpflug","year":"2006","journal-title":"Blood"},{"issue":"23","key":"2019111703122644300_B49","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2009-11-253120","article-title":"Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","volume":"115","author":"Golder","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111703122644300_B50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111703122644300_B51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0033-1353442","article-title":"Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect","volume":"39","author":"Othman","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"2019111703122644300_B52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease","volume":"19","author":"Larsen","year":"2013","journal-title":"Haemophilia"},{"issue":"1","key":"2019111703122644300_B53","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/j.1365-2516.2011.02676.x","article-title":"A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain","volume":"18","author":"Keeling","year":"2012","journal-title":"Haemophilia"},{"issue":"14","key":"2019111703122644300_B54","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood,"},{"issue":"9","key":"2019111703122644300_B55","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111703122644300_B56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1650401","article-title":"Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques","volume":"75","author":"Nesbitt","year":"1996","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111703122644300_B57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"2019111703122644300_B58","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"issue":"3","key":"2019111703122644300_B59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111703122644300_B60","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111703122644300_B61","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2516.2012.02848.x","article-title":"Analysis of F9 point mutations and their correlation to severity of haemophilia B disease","volume":"18","author":"Hamasaki-Katagiri","year":"2012","journal-title":"Haemophilia"},{"issue":"4","key":"2019111703122644300_B62","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2516.2008.01753.x","article-title":"Why does the mutation G17736A\/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?","volume":"14","author":"Knobe","year":"2008","journal-title":"Haemophilia"},{"issue":"21","key":"2019111703122644300_B63","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.2197.2197","article-title":"The synonymous V107V mutation in factor IX is not so silent and may cause hemophilia B in patients","volume":"116","author":"Kimchi-Sarfaty","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111703122644300_B64","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2011.055285","article-title":"High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods","volume":"97","author":"Corrales","year":"2012","journal-title":"Haematologica"},{"issue":"9","key":"2019111703122644300_B65","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/jth.12339","article-title":"Deep intronic \u201cmutations\u201d cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA","volume":"11","author":"Pezeshkpoor","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2019111703122644300_B66","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"2019111703122644300_B67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/humu.20403","article-title":"Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A","volume":"28","author":"Bogdanova","year":"2007","journal-title":"Hum Mutat"},{"issue":"S2","key":"2019111703122644300_B68","article-title":"F8 and F9 gene variants, CADD scores, and hemophilia severity: in the my life, our future genotyping project","volume":"13","author":"Johnsen","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/152\/1249549\/bep00115000152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/152\/1249549\/bep00115000152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T15:27:47Z","timestamp":1657294067000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2015\/1\/152\/20537\/Using-genetic-diagnostics-in-hemophilia-and-von"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,5]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2015.1.152","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,5]]}}}